Mironid® will be participating in the Polycystic Kidney Disease Regulatory Summit on May 19th and 20th hosted by the Polycystic Kidney Disease Outcomes Consortium and the PKD Foundation
Together with key stakeholders from the pharmaceutical industry and academic setting, foundations, patient advocacy groups, individuals living with PKD and regulatory agencies from around the world, the consortium will address current unmet drug development needs for PKD, identify tools that are needed to deliver new therapies to patients, and catalyze the development of a regulatory framework to enable advancement of new treatments.The Summit includes a series of three sessions with pre-recorded webinars available for registrants to view at their own pace two weeks prior to the meeting. On May 19 and 20, live presentations will summarize content from the pre-recorded webinars, followed by panel discussions with speakers to facilitate dialogue among all participants.